Ftse Mib
38.225,82
-0,95%
DAX
22.620,95
-1,65%
S&P 500
5.614,56
-2,70%
NASDAQ
17.468,32
-4,00%
Bitcoin
79.939,46
1,87%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gilead Sciences Inc (GILD) Gilead Sciences Inc (GILD) Notizie

Gilead Sciences Inc

GILD
117,87
0,46 (0,39%)
11 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202521:02EDGAR2Form 144 - Report of proposed sale of securities
05/3/202523:00EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
03/3/202522:26EDGAR2Form 144 - Report of proposed sale of securities
28/2/202522:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
24/2/202514:30BWEuropean Medicines Agency Validates Gilead’s Marketing..
21/2/202501:43EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
21/2/202501:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202522:30BWGilead’s Seladelpar Granted Conditional European Marketing..
19/2/202522:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:05BWGilead Sciences to Present at Upcoming Investor Conferences
18/2/202522:14EDGAR2Form 144 - Report of proposed sale of securities
18/2/202514:30BWU.S. FDA Accepts Gilead’s New Drug Applications for..
14/2/202503:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202522:22EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
12/2/202522:03EDGAR2Form 144 - Report of proposed sale of securities
11/2/202522:05BWGilead Sciences Announces 2.6 Percent Increase in First..
11/2/202522:04EDGAR2Form 8-K - Current report
11/2/202522:02BWGilead Sciences Announces Fourth Quarter and Full Year 2024..
06/2/202522:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202522:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202522:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202522:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202500:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202522:15EDGAR2Form 144 - Report of proposed sale of securities
31/1/202522:01EDGAR2Form 144 - Report of proposed sale of securities
30/1/202514:00PRNUSCognizant and Gilead Expand Partnership to Drive Greater..
28/1/202522:05BWGilead Sciences to Release Fourth Quarter & Full Year 2024..
27/1/202523:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202521:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202522:18EDGAR2Form 144 - Report of proposed sale of securities
11/1/202517:00BWGilead and LEO Pharma Enter Into Strategic Partnership to..
10/1/202521:46EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
04/1/202500:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202500:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/12/202402:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/12/202402:17EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
20/12/202422:05BWGilead Sciences to Present at Upcoming Investor Conference
19/12/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202414:30BWU.S. FDA Grants Breakthrough Therapy Designation to..
17/12/202413:00BWGilead and Terray Therapeutics Announce Multi-Target..
16/12/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:08EDGAR2Form 144 - Report of proposed sale of securities
13/12/202412:37BWGilead’s Seladelpar Receives Positive CHMP Opinion for..
12/12/202423:30BWGilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief..
12/12/202401:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 117,00 Min: 116,81 Max: 119,96
Chiusura: 117,41

La tua Cronologia

NASDAQ
GILD
Gilead Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci